Clinical Trial Update: A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effect of verinurad on heart electrical activity in healthy volunteers, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Verinurad (verinurad)

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Volunteers (Intended Indication: Chronic Kidney Disease) | Phase 1 | Status: COMPLETED | Results posted: 2022-01-31